Related Experiment Videos
New contrast agents for imaging the liver.
1Institute of Clinical Radiology, Ludwig-Maximilians-University, Klinikum Grosshadern, Munich, Germany. helmberg@ikra.med.uni-muenchen.de
Magnetic Resonance Imaging Clinics of North America
|November 6, 2001
Summary
Different contrast agents for liver imaging vary in how they work and what they show. While some agents reveal blood flow, others offer functional insights but face limitations due to tumor biology.
Area of Science:
- Medical Imaging
- Radiology
- Pharmacology
Background:
- Contrast agents are crucial for hepatic imaging, offering diverse diagnostic capabilities.
- These agents are categorized into nonspecific, extracellular space (ECS)-directed, reticuloendothelial system (RES)-selective, and hepatocyte-selective compounds.
Purpose of the Study:
- To review the characteristics and applications of various contrast agents used in hepatic imaging.
- To discuss the diagnostic utility and limitations of different contrast agent classes.
Main Methods:
- Literature review of contrast agents for hepatic imaging.
- Analysis of biodistribution, pharmacokinetics, contrast behavior, and tissue specificity.
- Evaluation of diagnostic efficacy based on tumor biology.
Main Results:
- Extracellular space (ECS) agents provide vascularization and perfusion data, akin to X-ray contrast agents.
- Reticuloendothelial system (RES)- and hepatocyte-selective agents offer functional information for enhanced tissue characterization.
- Tumor biology presents significant limitations for the diagnostic efficacy of tissue-specific contrast agents.
Conclusions:
- Hepatic contrast agents exhibit varied biodistribution and specificity, impacting their diagnostic value.
- While RES- and hepatocyte-selective agents provide functional insights, their efficacy is constrained by tumor heterogeneity.
- Understanding agent properties and tumor biology is key to optimizing hepatic imaging.